174 related articles for article (PubMed ID: 38576616)
1. Reduced serum IgG galactosylation is associated with increased inflammation during relapses of neuromyelitis optica spectrum disorders.
Gao S; Jiao X; Guo R; Song X; Li B; Guo L
Front Immunol; 2024; 15():1357475. PubMed ID: 38576616
[TBL] [Abstract][Full Text] [Related]
2. The frequencies of peripheral blood CD5
Khani L; Jazayeri MH; Nedaeinia R; Bozorgmehr M; Nabavi SM; Ferns GA
Allergy Asthma Clin Immunol; 2022 Jan; 18(1):5. PubMed ID: 35031055
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder.
Min W; Zhang L; Wang S; Xue M; Guo C; Zhu M
Mult Scler Relat Disord; 2023 Feb; 70():104517. PubMed ID: 36708681
[TBL] [Abstract][Full Text] [Related]
4. Resolution of inflammation in neuromyelitis optica spectrum disorders.
Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
[TBL] [Abstract][Full Text] [Related]
5. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum interleukin-39 levels in patients with neuromyelitis optica spectrum disorders correlated with disease severity.
Yang MG; Tian S; Zhang Q; Han J; Liu C; Zhou Y; Zhu J; Jin T
Mult Scler Relat Disord; 2020 Nov; 46():102430. PubMed ID: 32853892
[TBL] [Abstract][Full Text] [Related]
7. EBI2-expressing B cells in neuromyelitis optica spectrum disorder with AQP4-IgG: Association with acute attacks and serum cytokines.
Baek SH; Kim B; Shin JY; Choi SJ; Ahn SH; Choi YS; Kim SM; Sung JJ
J Neuroimmunol; 2021 Sep; 358():577637. PubMed ID: 34229205
[TBL] [Abstract][Full Text] [Related]
8. Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder.
Yuan C; Liu X; Cai S; Zhang L; Guo R; Jia Z; Sun Y; Li B
Mult Scler Relat Disord; 2023 Feb; 70():104504. PubMed ID: 36623394
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal evaluation of clinical characteristics of Chinese neuromyelitis optica spectrum disorder patients with different AQP4-IgG serostatus.
Zhang X; Liu X; Yu H; Deng B; Zhang Y; Chen X
Mult Scler Relat Disord; 2022 Jun; 62():103786. PubMed ID: 35429818
[TBL] [Abstract][Full Text] [Related]
10. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-36 alpha levels are elevated in the serum and cerebrospinal fluid of patients with neuromyelitis optica spectrum disorder and correlate with disease activity.
Song Y; Zhu M; Liu C; Zheng C; Zhou Y; Zhu J; Jin T
Immunobiology; 2019 May; 224(3):397-401. PubMed ID: 30852049
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the Clinical Characteristics in Patients with Neuromyelitis Optica Spectrum Disorders and Clinical Immune Indicators: A Retrospective Study.
Cai L; Shi Z; Chen H; Du Q; Zhang Y; Zhao Z; Wang J; Lang Y; Kong L; Zhou H
Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326328
[TBL] [Abstract][Full Text] [Related]
13. Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease.
Barreras P; Vasileiou ES; Filippatou AG; Fitzgerald KC; Levy M; Pardo CA; Newsome SD; Mowry EM; Calabresi PA; Sotirchos ES
Neurology; 2022 Nov; 99(22):e2504-e2516. PubMed ID: 36240094
[TBL] [Abstract][Full Text] [Related]
14. Th2 axis-related cytokines in patients with neuromyelitis optica spectrum disorders.
Zhang Y; Yao XY; Gao MC; Ding J; Hong RH; Huang H; Zhuang L; Wang YG; Hao Y; Guan YT
CNS Neurosci Ther; 2018 Jan; 24(1):64-69. PubMed ID: 29110391
[TBL] [Abstract][Full Text] [Related]
15. Correlation between serum levels of endothelin-1 and disease severity in patients with neuromyelitis optica spectrum disorders.
Yi M; Liu MQ; Chou LS; Jiang SM; Zhang LJ; Huang CN; Wang N; Zhang QX; Yang L
Immunobiology; 2020 May; 225(3):151959. PubMed ID: 32517881
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte Subsets Are Associated with Disease Status in Neuromyelitis Optica Spectrum Disorders.
Yang H; Liu W; Wu YF; Zhu DS; Shen XF; Guan YT
Neuroimmunomodulation; 2022; 29(4):296-305. PubMed ID: 34903694
[TBL] [Abstract][Full Text] [Related]
17. Serum Aquaporin 4-Immunoglobulin G Titer and Neuromyelitis Optica Spectrum Disorder Activity and Severity: A Systematic Review and Meta-Analysis.
Liu J; Tan G; Li B; Zhang J; Gao Y; Cao Y; Jia Z; Sugimoto K
Front Neurol; 2021; 12():746959. PubMed ID: 34744983
[No Abstract] [Full Text] [Related]
18. Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Bauer A; Rudzki D; Berek K; Dinoto A; Lechner C; Wendel EM; Hegen H; Deisenhammer F; Berger T; Höftberger R; Rostasy K; Mariotto S; Reindl M
Front Immunol; 2022; 13():1037812. PubMed ID: 36451827
[TBL] [Abstract][Full Text] [Related]
19. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Schindler P; Grittner U; Oechtering J; Leppert D; Siebert N; Duchow AS; Oertel FC; Asseyer S; Kuchling J; Zimmermann HG; Brandt AU; Benkert P; Reindl M; Jarius S; Paul F; Bellmann-Strobl J; Kuhle J; Ruprecht K
J Neuroinflammation; 2021 May; 18(1):105. PubMed ID: 33933106
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-33 as a Biomarker Affecting Intrathecal Synthesis of Immunoglobulin in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Wang M; Xia D; Sun L; Bi J; Xie K; Wang P
Eur Neurol; 2023; 86(4):256-262. PubMed ID: 37100033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
